All individual trials at Cortendo AB

An AllTrials project

All individual trials at Cortendo AB

2 out of 3

66.7%

$7,774,368

$0

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
reported-late	Cortendo AB	NCT01838551	An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome [pACT]	2018-04-30	692
reported	Cortendo AB	NCT03277690	A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome	2020-06-30
overdue	Cortendo AB	NCT03621280	An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome	2022-12-31	40

Download this data